Connection

Michael Lilly to Doxorubicin

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Doxorubicin.
Michael Lilly
Connection Strength
0.017
Doxorubicin
  1. Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway. Leukemia. 2008 Jan; 22(1):138-46.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.